Full Text View
Tabular View
No Study Results Posted
Related Studies
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
This study has been completed.
Study NCT00095056   Information provided by Merck
First Received: October 29, 2004   Last Updated: September 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Chronic Renal Insufficiency
Additional conditions recognized in this trial
Diabetes Mellitus
Renal Insufficiency
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Kidney Diseases
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
sitagliptin phosphate
Comparator: glipizide
Additional drug interventions recognized in this trial
Glipizide
Sitagliptin
More general drug interventions related to this trial
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services